longbridgelongbridge
  • 平台特色
    特色
    投资产品私人财富管理交易工具行情服务分析工具资讯服务开发者平台
    账户类型
    个人客户机构客户
  • Café
longbridge
© 2026 Longbridge|服务条款隐私政策

Lakewood-Amedex Biotherapeutics

LABT

----
开始交易
概览概览新闻新闻讨论讨论财务财务预测预测估值估值股东股东简况简况
LongbridgeAI
全部股东机构持有者内部人士

全部股东

股东类型

  • 个人与内部人士44.30%
  • 公众及其他38.25%
  • 私营企业12.01%
  • 机构投资者5.44%

主要股东

主要股东 最新
股东
Steve ParkinsonFormer CEO, President & Executive Director
19.69%46.66 万47.01%+02025/10/09
Thomas Kaufmann
14.50%34.36 万1.34%+1.002026/09/16
Lindesfarne LLC
9.75%23.10 万0.37%+2.76 万2026/09/16
Royal Caswell
5.32%12.60 万0.49%+1.002026/09/16
TLP Management, LP
3.29%7.80 万--+7.80 万2026/04/23
Ted BrownFormer Non-Executive Director
3.27%7.75 万107.58%-69.79 万2026/04/23
Marex Group Limited
2.03%4.82 万--+4.82 万2026/06/30
Hudson River Trading LLC
1.89%4.48 万--+4.48 万2026/06/30
Bortel Investment Management, LLC
1.19%2.82 万2.84%+02025/10/09
Peter CeccacciCFO & VP of Administration
0.47%1.11 万0.04%+1.002026/09/16
Leonard DeromaIndependent Director
0.31%7,457.000.03%+1.002026/09/16
Douglas ManionIndependent Chairman
0.22%5,181.000.02%+1.002026/09/16
UBS Asset Management AG
0.17%4,098.00--+4,098.002026/06/30
Geode Capital Management, LLC
0.06%1,493.00<0.01%+02026/07/31
Tower Research Capital Europe Limited
0.03%624.00--+624.002026/06/30
Osaic Wealth, Inc.
<0.01%138.00--+138.002026/06/30
Thrivent Trust Co.
<0.01%11.00--+11.002026/06/30
Kelvin CooperCEO, SVP of Research & Development and Director
0.00%0.000.00%+02026/04/23
Thomas BalzerChief Medical Officer & SVP of Clinical Development
0.00%0.000.00%+02026/04/23